Organization

Hematology Division at University of Washington Medical Center

5 abstracts

Abstract
Bromodomain and extra-terminal (BET) inhibitor INCB057643 in patients with relapsed or refractory myelofibrosis (MF) and other advanced myeloid neoplasms: A phase 1 study.
Org: Sylvester Cancer Center, AOU Careggi, Division of Hematology and Hematologic Malignancies, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Josep Carreras Leukemia Research Institute,
Abstract
Identification of factors to predict low risk febrile neutropenia admissions in patients with acute myeloid leukemia (AML) following intensive chemotherapy.
Org: University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, University of Washington Medical Center, Seattle Cancer Care Alliance, Fred Hutchinson Cancer Research Center,
Abstract
Evaluation of cardiac failure and recovery in acute myelogenous leukemia.
Org: University of Washington/Fred Hutchinson Cancer Center, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Hematology Division at University of Washington Medical Center, University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Research Center/University of Washington,
Abstract
Bromodomain and extra-terminal (BET) inhibitor INCB057643 (LIMBER-103) in patients (pts) with relapsed or refractory myelofibrosis (R/R MF) and other advanced myeloid neoplasms: A phase 1 study.
Org: Sylvester Cancer Center, Emory University School of Medicine, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Hospital Germans Trias i Pujol, Institut Català D'Oncologia,
Abstract
Effect of change in ECOG performance status at diagnosis and relapse in patients with acute myeloid leukemia.
Org: University of Washington and Fred Hutchinson Cancer Research Centre, Fred Hutchinson Cancer Center/Division of Hematology and Oncology, Hematology Division at University of Washington Medical Center, University of Washington Medical Center, Seattle Cancer Care Alliance,